European regulators granted HeartStitch CE mark approval for its Trans-Apical Access and Closure device. The suture-based system is intended for providing percutaneous transapical access in left-heart structural heart defect repairs, imitating surgical closure without the need for open heart surgery or limited thoracotomy access.
EU OKs HeartStitch's transapical access, closure device
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.